Are you more of a visual learner? Check out our online video lectures and start your respiratory system course now for free!

Needle biopsy

A physician’s hands are seen performing a needle biopsy to determine nature of lump either fluid-filled cyst or solid tumor.

Definition of Breast Carcinoma

Breast cancer, also known as mastocarcinoma, is a malignant tumor of the breast (mammary gland).

The point of origin of breast cancer may either be the mammary gland’s ducts or the lobules. Correspondingly, the 2 common breast cancer types, ductal carcinoma, and the lobular carcinoma are differentiated.


Diagram showing the lobes and ducts of a breast

Image: “Diagram showing the lobes and ducts of a breast” by Cancer Research UK. License: (CC BY-SA 4.0)

Breast cancer is the most common form of cancer among women, accounting for 29% of all malignant diseases among women in the United States. The yearly incidence adds up to 110 cases per 100,000 women.

More than 90% of diagnoses occur in women over 40 years of age, while the median age at the time of diagnosis of breast cancer is 61 years.

Note: One out of 8–10 women gets breast cancer during her lifetime! The chances of being affected with breast cancer increase with age, but young women also can be affected. It usually affects women between the ages of 60–80 years.

Note: In the western hemisphere, the most common cause of death among women in their 35th–55th year of life is breast cancer!

However, not only women, but breast cancers are also noted in men; 1% of breast cancers affect men.

Age-standardised death rates from Breast cancer by country (per 100,000 inhabitants)

Image: “Age-standardised death rates from breast cancer by country (per 100,000 inhabitants)” by Lokal_Profil. License: (CC BY-SA 2.5)

Etiology of Breast Cancer

Causes of breast cancer

The exact etiology of breast cancer is unknown, but it is assumed to be a multifactorial event. The majority of breast cancers forms spontaneously (= sporadically, approx. 95%), whereas only a minor fraction is of hereditary origin, in terms of familial genetic modifications (approx. 5%).

Risk factors for breast cancer

There are multiple risk factors that may promote the formation of breast cancer.

The most important population-related risk factor for the formation of breast cancer is advanced age.

With advanced age, the risk of contracting breast cancer increases. The other common risk factors include hormonal influences (endogenous or exogenous), positive family history (genetic predisposition), obesity, nulligravida, early menarche, late menopause, diet, and lifestyle. The following table gives you an overview:

Risk factors
Diet/lifestyle Large amounts of meat and fat, overweight/obesity (especially after menopause), high intake of alcohol, and cigarettes
Family history Breast cancer in 1st or 2nd-degree relatives (mother, grandmother, sister), and Ashkenazi Jewish descent
Hormonal influences Long hormone exposure: early menarche and late menopause; higher age at 1st delivery (> 30 years of age), nulliparity, hormone replacement therapy after menopause (> 5 years), oral contraceptives (disputable)
Others Breast cancer on the contralateral side, ionizing radiation, benign findings in a biopsy, mastopathy, and hyperprolactinemia

In the majority of hereditary breast cancers, a mutation on 1 of the following 2 tumor suppressor genes can be found. These genes are the “BReast-CAncer 1 and 2” BRCA-1 (on chromosome 17q) and BRCA-2 (on chromosome 13q).

Note: Women with BRCA-1 or BRCA-2-gene mutations have a higher risk (80–90%) of breast cancer. These women also have an increased risk of ovarian cancer.

Representation of the BRCA1 gene on chromosome 17

Image: “Representation of the BRCA1 Gene on Chromosome 17.” by Kuebi. License: (CC BY-SA 3.0).

Classification of Breast Carcinoma


The world health organization (WHO) classifies breast cancer into ductal and lobular carcinomas histopathologically on the basis of their origin. This classification covers invasive breast cancers as well as precursor lesions, lesions of low malignant potential, and benign lesions.

Note: Ductal carcinomas comprise 80% of breast cancers, while lobular carcinomas account for the remaining 20%. The following is an oversimplified overview of the WHO-classification:

Invasive breast carcinomas
  • Invasive carcinoma of no special type (NST)
  • Invasive lobular carcinoma
  • Tubular carcinoma
  • Cribriform carcinoma
  • Mucinous carcinoma
  • Carcinoma with medullary features
  • Carcinoma with signet ring differentiation
Epithelial-myoepithelial tumors
  • Pleomorphic adenoma
  • Adenomyoepithelioma
Precursor lesions
  • Ductal carcinoma in situ
  • Lobular neoplasia
    • Lobular carcinoma in situ
    • Atypical lobular hyperplasia
Papillary lesions
  • Intraductal papilloma
  • Intraductal papillary carcinoma
  • Encapsulated papillary carcinoma
  • Solid papillary carcinoma
Benign epithelial proliferations
  • Sclerosing adenosis
  • Apocrine adenosis
  • Microglandular adenosis
  • Radial scar/complex sclerosing lesion
  • Adenomas
Fibroepithelial tumors
  • Fibroadenoma
  • Phyllodes tumor
  • Hamartoma
Tumors of the nipple
  • Nipple adenoma
  • Syringomatous adenoma
  • Paget disease of the nipple

TNM-classification of the breast cancers

The Tumor, Nodes, and Metastasis (TNM)-classification is an important instrument to classify malignant tumors with regard to their spreading, affection of regional lymph nodes and the presence or absence of distant metastases. Using this classification, the prognosis and the treatment strategy is determined.

The following table depicts the TNM-classification of the mastocarcinoma using the classification of the UICC (Reference: Diagnostic breast center Munich).

Primary tumor (T)
TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
Tis Carcinoma in situ
T1 Tumor ≤ 20 mm in greatest dimension
T2 Tumor > 20 mm but ≤ 50 mm in greatest dimension
T3 Tumor > 50 mm in greatest dimension
T4 Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules)
Regional lymph nodes (N)
NX Regional lymph nodes cannot be assessed (eg, previously removed)
N0 No regional lymph node metastasis
N1 Metastasis to movable ipsilateral level 1, 2 axillary lymph node(s)
N2 Metastases in ipsilateral level 1, 2 axillary lymph nodes that are clinically fixed or matted


In clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastasis

N3 Metastases in ipsilateral infraclavicular (level 3 axillary) lymph node(s), with or without level 1, 2 axillary node involvement,


In clinically detected ipsilateral internal mammary lymph node(s) and in the presence of clinically evident level 1, 2 axillary lymph node metastasis.

Distant metastasis (M)
M0 No clinical or radiographic evidence of distant metastasis
M1 Distant detectable metastases as determined by classic clinical and radiographic means and/or histologically proven > 0.2 mm

Pathology and Pathophysiology of Breast Cancer

Histological examination of breast cancer

Invasive Lobular Carcinoma of the Breast

Image: “Invasive Lobular Carcinoma of the Breast” by Ed Uthman. License: (CC BY 2.0)

As already mentioned, breast cancer is classified in ductal or lobular and invasive or non-invasive (in situ) types. The ductal carcinoma in situ (DCIS) and the lobular carcinoma in situ (LCIS) remain locally and do not break through the basal membrane, whereas invasive carcinomas infiltrate the surrounding tissues. After a period of latency, the in-situ-carcinomas may develop into invasive carcinoma. The most frequent one is adenocarcinoma. 

Diagram showing ductal carcinoma in situ

Bild: “Diagram Showing Ductal Carcinoma in situ (DCIS)” von Cancer Research UK. Lizenz: (CC BY-SA 4.0)

The DCIS originates from the ducts of the mammary gland and may be differentiated differently: solid (most frequently), comedo-type, cribriform or papillary. The various subtypes are different in their progression, prognosis, and therapy.

In the case of the DCIS, central necrosis may develop into calcium-precipitation (‘micro-calcification’), which can be critical for diagnostics. The period of latency of the invasive ductal carcinoma is approx. 10 years.

Diagram showing lobular carcinoma in situ

Image: “Diagram Showing Lobular Carcinoma in situ (LCIS)” by Cancer Research UK. License: (CC BY-SA 4.0)

The LCIS originates from monomorphic cell proliferation with small tumor cells in the lobules of the mammary gland. The acini extend to a bulb-shaped form. The period of latency before transformation into an invasive lobular carcinoma is, being up to 25 years, longer than the period of latency of the DCIS, for which reason the LCIS is also named a pre-cancer. Often it is multicentric.

Clinical Symptoms of Breast Cancer

Localization and metastasis of breast cancer

Breast quadrant – breast cancer

Image: “Breast Quadrant – Breast Cancer” by Cadelli. License: Public Domain

Breast cancer is most frequently located (55%) in the upper outer quadrant of the breast due to increased breast density, whereas it is located retro-areolar in 15%, in the upper inner in 15% and in the lower outer quadrant in 10% of the cases. The lower inner quadrant is affected very rarely, amounting for only 5%.  

A carcinoma is said to be multifocal if multiple foci in the same quadrant are present. If it is multicentric, different quadrants of the breasts are affected. Furthermore, in 5–10% of cases, the contralateral breast is also affected by the tumor.

Breast cancers can metastasize at an early stage through lymphogenous and/or hematogenous routes:

Lymphogenous metastasis is into the regional lymph nodes of the axilla, while the hematogenous spread is into the skeleton (most common), lung, liver or brain. Also, metastasis into the ovaries is possible.

Affected axillary lymph nodes are used as an indicator of hematogenous metastasis. During further procedures, examinations that verify metastases in organs should follow. For this, a chest X-ray, ultrasonic examination of the liver and bone scintigraphy is used.

Diagram showing most common sites breast cancer spreads to

Image: “Diagram showing most common sites breast cancer spreads to” by Cancer Research UK. License: (CC BY-SA 4.0)

Symptoms of breast cancer

Breast cancer is often asymptomatic in the early stages. A dense palpable lump in the breast, which is detected by the patient herself in the majority of cases, is the leading symptom of breast cancer. Further symptoms are the following:

  • Changes in size, shape, and symmetry of the breast
  • Eczema of the nipple (always needs clarification!)
  • Skin changes in color or texture
  • Dimpled skin (plateau phenomenon)
  • Orange-peel-skin (peau d’orange)
  • Retraction of the nipple
  • Bloody nipple secretion
  • Swollen axillary lymph nodes
  • Localized chest pain (rarely)

Note: A palpable node always needs to be tested.

Early signs of breast cancer

Image: “Early Signs of Breast Cancer” by Morning2k. License: Public Domain

Special Types of Breast Cancer

The special types of breast cancer, inflammatory breast cancer and Paget’s disease of the nipple, are outlined briefly in the following section

Inflammatory breast cancer

The inflammatory breast cancer is rare and aggressive type of breast cancer that is characterized by erythema and pitting of the skin, orange-peel-skin, and breast swelling.   

Inflammatory Breast Cancer

Image: “(a) inflammatory breast cancer (IBC) case (b) IBC; erythema, edema and peau d’orange of the right breast, no tumor mass, duration of signs is 1 month; (c) IBC; erythema, edem, peau d’orange of the left breast, duration of signs is 12 months. (d) IBC; erythema, edema, peau d’orange of the right breast, duration of signs 72 months.” von openi. License: (CC BY 2.5)

It is accountable for 1–4% of all breast cancers. It is often hard to diagnose due to lack of a defined palpable tumor. Mammography and sonography often do not deliver distinct results.

Therapy includes neoadjuvant chemotherapy or radiation to be followed by surgery (modified radical mastectomy). Having a 5-year-survival-rate of only 5%, the prognosis of the inflammatory mastocarcinoma is poor.

Paget’s disease of the nipple

The Paget’s carcinoma grows intraepidermal ductal and appears in a nipple and/or areola changed due to eczema. It may be accompanied by a DCIS or invasive ductal carcinoma.

Paget Disease of the Nipple

Image: ‘Scaly, erythematous, crusty and thickened plaque on the nipple of Paget Disease of the Breast’ by Lily Chu. License: Public Domain

Since mammography is usually without pathological findings, exfoliative cytology is a proper way to detect the typical Paget cells (large cells, bright cytoplasm, and large round/oval nucleus). Magnetic resonance imaging (MRI) scans can be equally sensible.

For therapy, the modified radical mastectomy and, in individual cases, a breast-preserving therapy (BPT) comes into consideration, in which the therapy plan depends on the present type of carcinoma.

High magnification micrograph of extramammary Paget's disease

Image: ‘High magnification micrograph of extramammary Paget’s disease, abbreviated EMPD’ by Nephron. License: (CC BY-SA 3.0)

Note: With an eczematous nipple, Paget’s disease should always be ruled out! Further diagnostic and therapeutic steps can be found in the next article: The mastocarcinoma II – diagnosis, therapy, and prognosis.

Do you want to learn even more?
Start now with 1,000+ free video lectures
given by award-winning educators!
Yes, let's get started!
No, thanks!

Leave a Reply

Register to leave a comment and get access to everything Lecturio offers!

Free accounts include:

  • 1,000+ free medical videos
  • 2,000+ free recall questions
  • iOS/Android App
  • Much more

Already registered? Login.

Leave a Reply

Your email address will not be published. Required fields are marked *